Titan Pharmaceuticals Inc (TTNP)

[Serenity3]

Apple Tree was hoping to IPO & fund Braeburn with other people's money .. their S1, however, laid bare that Braeburn's strategy was not going to generate cash anytime soon... investor's did not take a bite .. so Apple Tree has limited options @this time.. sink > $ into Braeburn or sell assets & fold the company... agree it's generally good news for TTNP.. Braeburn will either sell their probuphine rights or focus resources on making it a success.. still hoping stronger entity buys the entire franchise in order to maximize the drug delivery potential of proneura... as I said before, Apple Tree will find it difficult to compete w/Indivior or Alkemes ... the depot shots are a crowded field in schizophrenia... in addition, it is very difficult to get consents from impaired patients who often do not want any medication at all, much less a long acting shot.. even in a prison setting getting a court order to force a PT even to take oral psychotropic medication requires convincing a judge that the PT's safety depends on him being involuntarily medicated against his will.. court orders, if granted, expire after a year and must again be renewed in court .. in the community, most agencies that I know of will not even attempt to go to court for an involuntary order to medicate .... I suspect Apple Tree did not consult field clinicians when they were hatching their strategic plan.... as for TTNP, right now it too needs cash